November 12, 2017
Last January Corwin Miller finished his postdoctoral training at Soll Lab to start a pharmaceutical company focused on developing new medicine. Recently, in a study published in the International Journal of Neuropsychopharmacology, they have already proven their experimental system is substantially faster and less expensive compared to prior drug development approaches. Today they are raising money to develop a new antidepressant drug. Please find more at:
https://www.indiegogo.com/projects/drugshoppe-fair-trade-pharmaceuticals-depression-medicine#/